Bell Potter - late August, but came my way yesterday.
Note that BP repeat the earning call assertion that growth will occur beyond the OS data for the big trials. They are suggesting 23% growth in the US this year. Being a high cost medical market where SIRT costs about $20k AU, this would be most welcome.
![]()
![]()
- Forums
- ASX - By Stock
- Comfort in UBS commentary
Bell Potter - late August, but came my way yesterday. Note that...
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SRX (ASX) to my watchlist
|
|||||
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M |
Open | High | Low | Value | Volume |
18.0¢ | 18.0¢ | 17.5¢ | $292.8K | 1.630M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 7394560 | 17.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 1260654 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 6894560 | 0.175 |
3 | 572000 | 0.170 |
2 | 27186 | 0.165 |
1 | 100000 | 0.160 |
1 | 387096 | 0.155 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 1260654 | 10 |
0.185 | 86569 | 2 |
0.190 | 87847 | 4 |
0.195 | 500000 | 1 |
0.200 | 451294 | 10 |
Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
Featured News
SRX (ASX) Chart |